World Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

World Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$342K	Sell	3,118 -323	-9%	-$33.5K	0.03%	545
2021 Q2	$322K	Buy	3,441 +65	+2%	+$5.98K	0.03%	637
2021 Q1	$319K	Sell	3,376 -241	-7%	-$20.3K	0.03%	661
2020 Q4	$265K	Buy	3,617 +110	+3%	+$8.18K	0.03%	702
2020 Q3	$272K	Buy	+3,507	New	+$241K	0.03%	601

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

World Asset Management's HZNP Position: Q3 2021 in Review

World Asset Management reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 9.4% in Q3 2021, selling an estimated $33.5K and leaving 3,118 shares worth $342K. The position accounts for 0.03% of the portfolio, ranked #545.

World Asset Management first reported a position in HZNP in Q3 2020 and has held it in 5 quarters since. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

World Asset Management held 3,118 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $342K as of Q3 2021.
World Asset Management sold 323 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $33.5K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.03% of World Asset Management's portfolio in Q3 2021, its #545 holding.
World Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and has held it in 5 quarters since.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.